HCA Healthcare Inc

Latest Report Overview

HCA Healthcare Inc (HCA) filed results for For the quarterly period ended March 31, 2026 (issuer fiscal Q1 FY2026; period ending 2026-03-31). HCA Healthcare Inc (HCA) reported under its latest quarterly financial statements for the period ended March 31, 2026 (Issuer fiscal Q1 2026) revenue of $19.109 billion (+4.3% YoY) and net income of $1.620 billion with diluted EPS of $7.15. The healthcare provider achieved a stable gross margin of 85.1% and operating cash flow of $2.014 billion, although free cash flow of $895 million was impacted by ongoing capital expenditures supporting infrastructure expansions. Management highlighted steady demand across its hospital networks, driven by robust outpatient services and inpatient volumes. The company continues to advance its digital capabilities and execute on its multi-year capital expenditure programs to expand capacity in high-growth markets. High-density geographic footprints in states like Florida and Texas continue to provide steady patient pipelines, offsetting some of the broader industry pressures on commercial reimbursement rates. Operationally, HCA remains focused on managing healthcare professional staffing shortages and labor cost inflation, which have historically pressured operating margins. The company continues to actively deploy capital toward expanding outpatient facilities, integrating new clinical technologies, and repurchasing common shares to drive long-term shareholder value.

Key Takeaways for HCA Healthcare Inc

• HCA Healthcare reported stable Q1 2026 revenue of $19.109 billion (+4.3% YoY) with diluted EPS rising to $7.15, supported by consistent patient volumes and outpatient demand.
• The company executed a massive $1.571 billion stock repurchase program in Q1 2026, following a $2.558 billion buyback in Q4 2025, demonstrating aggressive capital returns to shareholders.
• HCA's balance sheet remains highly leveraged, carrying $48.023 billion in total debt against a cash balance of just $940 million as of March 31, 2026.
• Staffing shortages and intense competition for experienced nurses and other healthcare professionals continue to act as major structural cost and operational risks.
• The business is highly sensitive to regional developments, with a significant concentration of operations and facilities located in Florida and Texas.
• HCA is actively transitioning to a new Electronic Health Record (EHR) platform and expanding clinical AI capabilities to drive operational efficiencies.

What Does HCA Healthcare Inc Do?

HCA Healthcare, Inc. is one of the leading health care services companies in the United States. As of December 31, 2025, the company operated 190 hospitals, comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals. In addition, HCA operated 121 freestanding ambulatory surgery centers (ASCs) and 31 freestanding endoscopy centers, spanning 19 states and England. The company's general, acute care hospitals provide a full range of medical specialties, including internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics, and obstetrics, as well as diagnostic and emergency services. HCA also operates a massive outpatient network including freestanding emergency care facilities, urgent care clinics, physician practices, diagnostic imaging centers, and home health or hospice agencies. This local market density and clinical variety allow HCA to provide comprehensive local networks backed by enterprise-scale resources.

Growth Drivers for HCA Healthcare Inc

• Expansion of ambulatory surgery centers (ASCs) and urgent care networks to capture profitable outpatient procedural demand [4.1].
• Digital health transformation, including the deployment of a new clinical Electronic Health Record (EHR) platform to drive hospital throughput.
• Recruitment and retention of specialized physicians to build comprehensive local clinical lines of business.
• Active expansion of inpatient beds and facility footprints in high-growth markets like Florida and Texas.
• Enhanced data analytics and AI capabilities to improve clinical diagnostic efficiency and back-office administrative automation.